Emergent 3 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Emergent 3. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Emergent 3 Today - Breaking & Trending Today

KarXT Effective in Improving Schizophrenia Symptoms at 52 Weeks

EMERGENT-3 trial showed xanomeline-trospium was effective in improving schizophrenia symptoms at 52 weeks, for participants who took either placebo or KarXT in acute trials. ....

Bristol Myers Squibb , Roland Chen , C Andrew Miller , Cenexel Hassman Research Institute Elan Cohen , Schizophrenia International Research Society , Cenexel Hassman Research Institute , Drug Administration , Elan Cohen , Myers Squibb , Annual Congress , Cenexel Hassman Research , New Drug Application , Rishi Kakar , Segal Trials , Negative Syndrome Scale , Clinical Global Impression Severity , Schizophrenia At The , Bristol Myers , Xanomeline Trospium Drug Application , Xanomeline Trospium , Emergent Trials , Emergent 2 , Emergent 3 , Emergent 4 , Schizophrenia Treatment , Schizophrenia In Adults ,